Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/4/12  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Barbara White

Wrong Dr. Barbara White?

Senior Vice President and Head of...

Phone: (305) ***-****  HQ Phone
Stiefel Laboratories , Inc.
255 Alhambra Circle
Coral Gables, Florida 33134
United States

Company Description: Founded in 1847, Stiefel Laboratories (a privately held company) is the world's largest independent pharmaceutical company specializing in dermatology. The company...   more
Background

Employment History

  • Head, Global Research and Development
    Stiefel Laboratories , Inc.
  • Senior Director
    MedImmune , Inc.
  • Vice President, Clinical Development
    MedImmune , Inc.
  • Head, Global Research and Development
    MedImmune , Inc.
  • Professor of Medicine In the Division of Rheumatology, Department of Medicine
    University of Maryland School of Medicine
  • Professor of Medicine and Vice Chair of Research, Department of Medicine
    University of Maryland School of Medicine
  • Associate Chief of Staff of the Research Service
    Baltimore Veteran Administration Medical Center
  • Vice President and Head of Immunology Therapeutic Area
    UCB
  • M.D., Vice President, Therapeutic Area Immunology, Global Projects and Development
    UCB

Board Memberships and Affiliations

Education

  • M.D.
  • medical degree
    University of Pennsylvania School of Medicine
  • MD
58 Total References
Web References
Barbara ...
www.stiefel.com, 4 Nov 2012 [cached]
Barbara White
Head, Global Research & Development, Stiefel, a GSK company
Barbara White, MD, joined Stiefel as head of global research & development in June 2011. In this role, she provides overall worldwide leadership to Stiefel’s R&D function, with responsibility for all research and product development activities at Stiefel, including prescription and consumer products.
Barbara joined Stiefel from UCB where she was vice president and head of immunology therapeutic area and has held prior roles at MedImmune and Amgen.
Prior to her pharmaceutical career, Barbara was professor of medicine and vice chair of research, department of medicine, at the University of Maryland School of Medicine.
She was formerly associate Chief of staff, research service at the Baltimore Veteran Administration (VA) medical center, one of the largest VA-based research programs in the country, where her research focused on immune-mediated mechanisms of lung fibrosis in scleroderma. Barbara also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center.
Barbara received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.
May 30,2012
www.stiefel.com, 30 May 2012 [cached]
"I'm delighted to build upon Stiefel's clinical pipeline of novel dermatology assets with the acquisition of WBI-1001" said Barbara White, Senior Vice President and Head of Research and Development, Stiefel "We have a strong commitment to patients with skin conditions and are excited to undertake development of this innovative agent."
MedImmune
www.cellectivetherapeutics.com, 2 April 2007 [cached]
The new executive appointments include Iksung Cho, vice president, biostatistics Anthony J. Coyle, Ph.D., vice president, R&D, and head, inflammation and autoimmunity research and Barbara White, M.D., vice president, clinical development, inflammatory disease.
...
Similarly, Anthony and Barbara have used their depth of experience and knowledge to advance important programs within our growing inflammatory disease portfolio."
...
Barbara White, M.D., now serves as vice president, clinical development, inflammatory disease. She joined MedImmune in January 2006 as senior director, and was appointed head of the inflammatory disease group in clinical development in November 2006. Prior to joining MedImmune, Dr. White was a director of medical affairs, inflammation therapeutic area, at Amgen where her activities included leading non-registration internal and external clinical research programs. Prior to 2003, Dr. White served as professor of medicine in the division of rheumatology, department of medicine, at the University of Maryland School of Medicine. She was formerly associate chief of staff of the research service at the Baltimore Veteran Administration (VA) Medical Center, one of the largest VA-based research programs in the country, where her research focused on immune-mediated mechanisms of lung fibrosis in scleroderma. Dr. White also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. She has been active in the American College of Rheumatology, serving as chair of the research committee and as a member of the board of directors, and has served as an ad hoc member of the FDA Arthritis Advisory Committee. She has served on the editorial boards of Arthritis & Rheumatism and Arthritis Care and Research and has been a reviewer for numerous journals and grant review panels. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board certified in Internal Medicine, Rheumatology and Allergy/Clinical Immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.
Stiefel, a GSK company- Leadership Team
www.stiefel.com, 4 Nov 2012 [cached]
Barbara White, our head of global research and development, talks about technology capabilities. Learn about advancing research technology
...
Barbara White Head, Global Research & Development, Stiefel, a GSK company
...
"Barbara provides overall worldwide leadership to Stiefel's R&D function, with responsibility for all research and product development activities…"
dari Stiefel dengan akuisisi WBI-1001," ...
indonesia.asiaprnews.com, 31 May 2012 [cached]
dari Stiefel dengan akuisisi WBI-1001," ungkap Barbara White, Wakil Presiden
...
"I'm delighted to build upon Stiefel's clinical pipeline of novel dermatology assets with the acquisition of WBI-1001," said Barbara White, Senior Vice President and Head of Research and Development, Stiefel.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304